# ARHGAP22

## Overview
ARHGAP22 is a gene that encodes the protein Rho GTPase activating protein 22, commonly referred to as RhoGAP22. This protein is a member of the Rho GTPase-activating protein family, which plays a pivotal role in the regulation of Rho GTPases, key molecular switches involved in various cellular processes such as cytoskeletal organization, cell migration, and gene transcription. RhoGAP22 functions as a GTPase activating protein (GAP), enhancing the intrinsic GTPase activity of Rho GTPases, thereby facilitating their inactivation. Structurally, RhoGAP22 contains an N-terminal pleckstrin homology (PH) domain, a RhoGAP domain, and a C-terminal coiled-coil (CC) domain, which are essential for its interactions with other proteins and its regulatory functions (Hu2012The; Longatti2021Arhgap22). The protein is ubiquitously expressed in mammals, with notable roles in the central nervous system, particularly in synaptogenesis and dendritic spine formation, where it interacts with proteins such as interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) (Longatti2021Arhgap22). Additionally, ARHGAP22 has been implicated in various pathological conditions, including neurological disorders and cancer, due to its regulatory influence on RAC1 activity and cell migration (Hu2012The; Longatti2021Arhgap22).

## Structure
The ARHGAP22 protein, also known as RhoGAP22, is a member of the RhoGAP family and plays a role in regulating Rho GTPases, which are crucial for cytoskeletal organization and gene transcription. The protein structure of ARHGAP22 includes an N-terminal pleckstrin homology (PH) domain, a RhoGAP domain, and a C-terminal coiled-coil (CC) domain (Hu2012The; Longatti2021Arhgap22). The PH domain is essential for its interaction with 14-3-3 proteins, which are involved in signal transduction pathways (Hu2012The). 

ARHGAP22 has been identified as an Akt substrate, with phosphorylation occurring at Ser16, a medium-stringency 14-3-3 binding site (Hu2012The). The interaction between ARHGAP22 and 14-3-3 proteins is characterized by a weak affinity with a stoichiometry of one ARHGAP22 molecule per 14-3-3 dimer (Hu2012The). The protein's interaction with 14-3-3 is facilitated by the PH domain, while the RhoGAP domain does not significantly interact with 14-3-3 (Hu2012The). 

The study of ARHGAP22's structure has not detailed its primary, secondary, tertiary, or quaternary structures, nor has it discussed splice variant isoforms beyond the phosphorylation sites (Hu2012The).

## Function
The ARHGAP22 gene encodes a protein known as RhoGAP22, which is a member of the Rho GTPase activating protein family. This protein plays a crucial role in the regulation of the actin cytoskeleton, a key component of cellular structure and function. ARHGAP22 functions as a GTPase activating protein (GAP) that enhances the intrinsic activity of Rho GTPases, leading to their inactivation. Specifically, ARHGAP22 inhibits the activity of RAC1, a member of the Rho GTPase family, which is involved in actin polymerization and dynamics (Longatti2021Arhgap22).

In healthy cells, ARHGAP22 is involved in maintaining proper cellular processes such as cell migration, vesicle trafficking, and differentiation. It is ubiquitously expressed in mammals, with higher expression in highly vascularized tissues. In the central nervous system, ARHGAP22 is expressed during synaptogenesis and is localized at the post-synaptic site of excitatory synapses, where it interacts with interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) to induce dendritic spine formation (Longatti2021Arhgap22). The absence of ARHGAP22 leads to RAC1 hyperactivity, increased dendritic spine density, and defects in synaptic structure and function, which can affect cognitive functions and behavior (Longatti2021Arhgap22).

## Clinical Significance
ARHGAP22 has been implicated in various neurological and cognitive conditions due to its role in regulating RAC1 activity. Disruption of ARHGAP22 leads to RAC1 hyperactivity, which affects hippocampal glutamatergic synapses and cognition in mice. This disruption results in increased dendritic spine density, defects in synaptic structure, and impaired synaptic plasticity, which are associated with cognitive impairments and reduced anxiety-like behavior (Longatti2021Arhgap22). Behavioral tests in ARHGAP22 knockout mice reveal strong impairments in learning and memory, aligning with findings in other models of intellectual disability, suggesting a potential link to conditions characterized by cognitive dysfunctions, such as fragile X syndrome (Longatti2021Arhgap22).

In cancer research, ARHGAP22 is noted for its role in cell migration and invasion. It is identified as an Akt substrate that interacts with 14-3-3 proteins, playing a role in cancer cell movement by inactivating Rac (Hu2012The). Although ARHGAP22 is listed among upregulated ARHGAPs in pancreatic adenocarcinoma, specific mutations or alterations in ARHGAP22 have not been directly linked to this or other specific diseases (Fei2024Integrated).

## Interactions
ARHGAP22, also known as RhoGAP22, is a Rho GTPase-activating protein that interacts with several proteins to regulate cellular processes. It specifically inhibits RAC1 activity through its GTPase-activating protein (GAP) activity, converting RAC1 to its inactive GDP-bound state. This interaction is crucial for regulating actin cytoskeleton dynamics, which are important for cell migration and synaptic function (Longatti2021Arhgap22).

ARHGAP22 is involved in the regulation of endothelial cell angiogenesis by interacting with RAC1, which assists in endothelial cell capillary tube formation during angiogenesis (Huang2018High). It also binds to 14-3-3 proteins in an insulin-responsive manner, which is part of the signal transduction pathway regulating endothelial cell function (Huang2018High).

In the context of synaptic regulation, ARHGAP22 interacts with the interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) protein to induce dendritic spine formation, playing a critical role in hippocampal excitatory synapse formation and function (Longatti2021Arhgap22). The absence of ARHGAP22 leads to RAC1 hyperactivity, affecting synaptic structure and plasticity, which can be restored by inhibiting RAC1 activity (Longatti2021Arhgap22).


## References


[1. (Fei2024Integrated) Haoran Fei, Xiao Shi, Dan Sun, Haishen Yang, Dali Wang, Kai Li, Xinxin Si, and Wei Hu. Integrated analysis identified the role of three family members of arhgap in pancreatic adenocarcinoma. Scientific Reports, May 2024. URL: http://dx.doi.org/10.1038/s41598-024-62577-z, doi:10.1038/s41598-024-62577-z. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-62577-z)

[2. (Hu2012The) Shu-Hong Hu, Andrew E. Whitten, Gordon J. King, Alun Jones, Alexander F. Rowland, David E. James, and Jennifer L. Martin. The weak complex between rhogap protein arhgap22 and signal regulatory protein 14-3-3 has 1∶2 stoichiometry and a single peptide binding mode. PLoS ONE, 7(8):e41731, August 2012. URL: http://dx.doi.org/10.1371/journal.pone.0041731, doi:10.1371/journal.pone.0041731. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0041731)

[3. (Longatti2021Arhgap22) Anna Longatti, Luisa Ponzoni, Edoardo Moretto, Giorgia Giansante, Norma Lattuada, Maria Nicol Colombo, Maura Francolini, Mariaelvina Sala, Luca Murru, and Maria Passafaro. Arhgap22 disruption leads to rac1 hyperactivity affecting hippocampal glutamatergic synapses and cognition in mice. Molecular Neurobiology, 58(12):6092–6110, August 2021. URL: http://dx.doi.org/10.1007/s12035-021-02502-x, doi:10.1007/s12035-021-02502-x. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-021-02502-x)

[4. (Huang2018High) Yu-Chuen Huang, Wen-Ling Liao, Jane-Ming Lin, Ching-Chu Chen, Shih-Ping Liu, Shih-Yin Chen, Yu-Ning Lin, Yu-Jie Lei, Huan-Ting Liu, Yu-Jen Chen, and Fuu-Jen Tsai. High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with arhgap22 expression. Oncotarget, 9(25):17858–17866, April 2018. URL: http://dx.doi.org/10.18632/oncotarget.24909, doi:10.18632/oncotarget.24909. This article has 7 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.24909)